1Govindan R,Page N,Morgensztern D,et al.Changing epidemiology of small-cell lung cancer in the Untied States over the last 30years:analysis of the surveillance,epidemiologic,and end results database[J].J Clin Oncol,2006,24(28):4539-4544.
2Sundstrm S,Bremnes RM,Kaasa S,et al.Cisplatin and etoposide regimen is superior to cyclophosphamide,epirubicin,and vincristine regimen in small-cell lung cancer:results from a randomized phaseⅢtrial with 5years'follow-up[J].J Clin Oncol,2002,20(24):4665-4672.
3Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer[J].N Engl J Med,2002,346(2):85-91.
4Hermes A,Bergman B,Bremnes R,et al.Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:a randomized phaseⅢtrial[J].J Clin Oncol,2008,26(26):2038-2043.
5Lima JP,dos Santos LV,Sasse EC,et al.Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer:systematic review with meta-analysis[J].J Thorac Oncol,2010,5(12):1986-1993.
